PGP and cancer: Although P-gp was first identified in drug-resistant cancer cells, it is also expressed in a wide variety of normal tissues (small intestine, liver, and kidney) as well as in blood-tissue barriers (23), serving as an efflux transporter against the entry of toxic xenobiotics, such as therapeutic drugs, dietary compounds, and environmental toxins, into the tissues (24).